巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    Amicus Therapeutics

    FOLD
    7.945
    0.030
    0.32%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・Amicus Therapeutics - 延遲價格・最後更新於 27/05 12:14
    最高位
    7.975
    最低位
    7.350
    開市價
    --
    前收市價
    7.920
    成交量(千)
    247.58
    成交額(百萬)
    14.42
    買入
    --
    賣出
    --
    每手股數
    --
    市值(百萬)
    2,225.89
    市盈率
    --
    息率
    --
    差價
    --
    52週高低
    12.530 - 5.910
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    Amicus Therapeutics
    證券代碼
    FOLD.US
    所屬板塊
    Biotechnology
    公司業務
    Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio.
    發行量
    278638872
    公司總部
    3675 Market Street
    公司網址
    https://www.amicusrx.com
    公司電郵
    ir@amicusrx.com
    公司電話
    +1 215 921-7600
    暫無內容

    關於

    Amicus Therapeutics(FOLD.US)所屬的行業板塊為Biotechnology。
    Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio.
    詳細公司背景可參考: https://www.amicusrx.com